4 biotech Stocks Facing FDA rejection!
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific...
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific...
Gritstone Bio, Inc. (NASDAQ: GRTS), formerly known as Gritstone Oncology, is a clinical-stage biotechnology company developing targeted immunotherapies for a range of diseases...
While Industries across the globe are grappling with the pandemic and its impact on their operations, Technology Industry has been focused on minimizing...
Conduent, Inc. (NASDAQ: CNDT) offers solutions for automation and analytics, to businesses and governments worldwide, in areas such as business processing, customer experience...
RegenxBio, Inc (NASDAQ: RGNX) is a clinical-stage biotechnology company which is cementing its place as a global leader in gene therapies, targeting the...
Biotech Companies continue to show resurgence with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and...
Impinj, Inc. (NASDAQ: PI) is a premier cloud connectivity platform offering products and services which help provide wireless connectivity, and information pertaining to...
Clovis Oncology Inc (NASDAQ: CLVS) is a commercial stage biotechnology company engaged in developing and commercializing oncology treatments worldwide. The Company develops diagnostic...
Alopecia Areata is an autoimmune/polygenic skin disease that causes loss of hair on the scalp and face and is estimated to affect over...